By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Neurochem, Inc. 

275 Armand-Frappier Boulevard

Laval  Quebec  H7V 4A7  Canada
Phone: 450-680-4500 Fax: 450-680-4501



Company News
Neurochem, Inc. (NRMX) to Officially Adopt New Name, BELLUS Health 4/15/2008 10:06:03 AM
Neurochem, Inc. (NRMX)'s Annual and Special Meeting of Shareholders April 15, 2008 4/14/2008 8:12:36 AM
Neurochem, Inc. (NRMX) Annual and Special Meeting of Shareholders 4/11/2008 10:33:56 AM
Neurochem, Inc. (NRMX) Moves Eprodisate Drug Development Program Forward for Amyloid A Amyloidosis 3/13/2008 6:40:36 AM
Neurochem, Inc. (NRMX) Reports Results for Fourth Quarter and Fiscal Year 2007 2/21/2008 6:55:13 AM
Neurochem, Inc. (NRMX) to Present at 2008 Biotechnology Industry Organization (BIO) CEO & Investor Conference - Presentation will be WebCast Live 2/11/2008 2:40:45 PM
Neurochem, Inc. (NRMX) Appoints Mr. Gary Schmid as CEO of New Unit 1/30/2008 6:59:39 AM
Neurochem, Inc. (NRMX) to Present at JPMorgan Healthcare Conference 1/3/2008 2:54:08 PM
Neurochem, Inc. (NRMX) Announces European Opinion for Eprodisate (KIACTA(TM)) 12/14/2007 7:40:40 AM
Neurochem, Inc. (NRMX) Announces Eprodisate (KIACTA(TM)) Receives Acknowledgement of Complete Response and is Granted Class 2 Review 12/7/2007 8:23:34 AM